You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Herpes simplex virus typeⅠ

Showing 1 - 25 of 7,477
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervical Cancer, Endometrial Cancer, Advanced Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type ?

Recruiting
  • Cervical Cancer
  • +2 more
  • Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
  • Shanghai, Shanghai, China
    Shanghai Tenth People's Hospital
Mar 31, 2023

Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue Trial in Xi'an (Recombinant oncolytic herpes simplex virus type ? (R130))

Recruiting
  • Osteosarcoma
  • +3 more
  • Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
  • Xi'an, Shaanxi, China
    Xi'an Honghui Hospital
May 8, 2023

Ovarian Cancer, Peritoneal Carcinomatosis, Fallopian Tube Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus

Recruiting
  • Ovarian Cancer
  • +2 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Shanghai, Shanghai, China
    Shanghai Tenth People's Hospital
Mar 26, 2023

Sarcoma, Carcinoma, Digestive Cancer Trial in Linyi (Recombinant oncolytic herpes simplex virus type 1 (R130))

Recruiting
  • Sarcoma
  • +9 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Linyi, Shandong, China
    Linyi Central Hospital
Jul 25, 2023

Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))

Recruiting
  • Sarcoma
  • +8 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Shanghai, Jiangsu, China
    Xuzhou Second People's Hospital
May 8, 2023

Virus, HSV-1, Herpes Simplex 1 Trial in Pocatello, Saint George (Purell Hand Sanitizer, Medical Grade Mineral Oil)

Recruiting
  • Virus
  • +3 more
  • Purell Hand Sanitizer
  • Medical Grade Mineral Oil
  • Pocatello, Idaho
  • +2 more
Nov 13, 2023

Head Neck Cancer, Esophageal Cancer, Otorhinolaryngologic Tumors Trial in Shanghai (Recombinant oncolytic herpes simplex virus

Recruiting
  • Head and Neck Cancer
  • +6 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Shanghai, China
    Eye & ENT Hospital of Fudan University
Apr 13, 2023

Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1

Recruiting
  • Lung Cancer
  • +11 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Anqing, Anhui, China
    The PLA Navy Anqing Hospital
May 23, 2023

HSV Trial (Pritelivir)

Available
  • HSV
  • (no location specified)
Apr 25, 2023

Frequency of Symptomatic Herpes Virus I and II in HIV Infected

Recruiting
  • HIV Disease
  • +2 more
  • Blood draw
  • Los Angeles, California
    Global Research Institute
Apr 9, 2023

NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

Suspended
  • HSV-2 Infection
  • Herpes Simplex Virus Infection
  • Diagnostic Test: NOWDx HSV-2 Test
  • Tempe, Arizona
  • +2 more
Sep 29, 2022

Protein Biomarkers in Neonatal Herpes Simplex Virus Infection

Completed
  • Neonatal Herpes Simplex Infection
  • +7 more
    • Copenhagen, Denmark
    • +1 more
    Dec 25, 2022

    Neonatal Herpes Simplex Infection Trial in Birmingham (Valacyclovir)

    Recruiting
    • Neonatal Herpes Simplex Infection
    • Birmingham, Alabama
      University of Alabama - Children's of Alabama
    Sep 12, 2022

    Herpes Simplex-virus Type 1 (HSV-1) Reactivation

    Recruiting
    • Tracheobronchitis
    • Herpes Simplex Infection
    • Patients with herpes-simplex infection requiring bronchoscopy
    • Münster, Germany
      University Hospital Münster
    Apr 11, 2022

    Pneumonia, Viral, Ventilator Associated Pneumonia, Community-acquired Pneumonia Trial (Acyclovir)

    Not yet recruiting
    • Pneumonia, Viral
    • +4 more
    • (no location specified)
    Nov 16, 2023

    Melanoma Trial in Beijing (OH2 injection, HX008 injection)

    Recruiting
    • Melanoma
    • OH2 injection
    • HX008 injection
    • Beijing, Beijing, China
      Peking University Cancer Hospital
    Jan 28, 2023

    Genital Herpes Simplex Type 2 Trial (BNT163, Placebo)

    Not yet recruiting
    • Genital Herpes Simplex Type 2
    • BNT163
    • Placebo
    • (no location specified)
    Jun 21, 2022

    Herpes Labialis Trial in Germany (drug, behavioral, procedure)

    Active, not recruiting
    • Herpes Labialis
    • HDIT101 (blinded therapy)
    • +5 more
    • Berlin, Germany
    • +4 more
    Jan 26, 2023

    Herpes Simplex Oral Trial in Murray (EDTA, Abreva)

    Enrolling by invitation
    • Herpes Simplex Oral
    • Murray, Utah
      University of Utah MidValley Dermatology
    Jan 25, 2022

    HSV, Herpes Labialis Trial in Saint Paul (Squaric Acid Dibutyl Ester)

    Completed
    Has Results
    • HSV
    • Herpes Labialis
    • Squaric Acid Dibutyl Ester
    • Saint Paul, Minnesota
      Prism Clinical Research, LLC
    Oct 5, 2021

    Breast Cancer, Ductal Carcinoma, Invasive Breast Carcinoma Trial in Tampa (Talimogene laherparepvec, Paclitaxel)

    Active, not recruiting
    Has Results
    • Breast Cancer
    • +3 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Nov 10, 2022

    Solid Tumor, Melanoma Trial in Beijing (OH2 injection, Keytruda)

    Recruiting
    • Solid Tumor
    • Melanoma
    • Beijing, Beijing, China
      Peking University Cancer Hospital
    Apr 1, 2022

    Recurrent Genital Herpes Trial (UB-621)

    Not yet recruiting
    • Recurrent Genital Herpes
    • UB-621
    • (no location specified)
    May 16, 2022

    Herpes Simplex Virus Keratitis Trial in New York (oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily, oral acyclovir 400 mg

    Withdrawn
    • Herpes Simplex Virus Keratitis
    • oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily
    • oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily + topical corticosteroid eye drops
    • New York, New York
      New York University School of Medicine
    Dec 29, 2021

    Pancreatic Cancer Trial in Chongqing (OH2 injection)

    Recruiting
    • Pancreatic Cancer
    • OH2 injection
    • Chongqing, Chongqing, China
      Chongqing University Cancer Hospital
    Jan 27, 2022